UK Markets open in 35 mins
NIKKEI 225
27,999.96 -175.94 (-0.62%) HANG SENG
20,005.52 -40.25 (-0.20%) CRUDE OIL
91.01 +0.25 (+0.28%) GOLD FUTURES
1,803.10 -2.10 (-0.12%) DOW
32,832.54 +29.04 (+0.09%) BTC-GBP
19,712.00 +88.22 (+0.45%)
Paratek Pharmaceuticals, Inc. (PRTK)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 2.6100 |
| Open | 2.6400 |
| Bid | 0.0000 x 800 |
| Ask | 0.0000 x 800 |
| Day's range | 2.6400 - 2.8100 |
| 52-week range | 1.6000 - 5.9800 |
| Volume | |
| Avg. volume | 576,938 |
| Market cap | 138.521M |
| Beta (5Y monthly) | 1.46 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 31 Oct 2014 |
| 1y target est | N/A |
- Motley Fool
Paratek Pharmaceuticals (PRTK) Q2 2022 Earnings Call Transcript
Participants on today's call are Evan Loh, M.D., chief executive officer; Adam Woodrow, president and chief commercial officer; and Randy Brenner, chief development and regulatory officer. Michael Bigham, executive chairman, and I will also be available for questions.
- Zacks
Paratek Pharmaceuticals (PRTK) Reports Q2 Loss, Tops Revenue Estimates
Paratek (PRTK) delivered earnings and revenue surprises of 5.71% and 3.45%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Could The Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Ownership Structure Tell Us Something Useful?
The big shareholder groups in Paratek Pharmaceuticals, Inc. ( NASDAQ:PRTK ) have power over the company. Large...
© 2022 Yahoo. All rights reserved.
